Literature DB >> 12902469

Selective inhibition of T cell activation via CD147 through novel modulation of lipid rafts.

Günther Staffler1, Andreas Szekeres, Gerhard J Schütz, Marcus D Säemann, Elisabeth Prager, Maximilian Zeyda, Karel Drbal, Gerhard J Zlabinger, Thomas M Stulnig, Hannes Stockinger.   

Abstract

The plasma membrane is compartmentalized into microdomains and the association/dissociation of receptors and signaling molecules with/from these membrane domains is a major principle for regulation of signal transduction. By following the reorganization of microdomains on living cells and performing biochemical studies, we show that Ab targeting of the T cell activation-associated Ag CD147 prevents TCR stimulation-dependent reorganization and clustering of microdomains. Triggering CD147 induces a displacement of the GPI-anchored coreceptors CD48 and CD59 from microdomains in human T lymphocytes. This perturbation of microdomains is accompanied by a selective inhibition of TCR-mediated T cell proliferation. The CD147-inhibited cells secret normal levels of IL-2 but acquire reduced amounts of the IL-2 receptor alpha-chain CD25. These results indicate that negative regulating signals can modulate microdomains and suggest a general mechanism for inhibition of receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902469     DOI: 10.4049/jimmunol.171.4.1707

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta.

Authors:  Kulandaivelu S Vetrivel; Xulun Zhang; Xavier Meckler; Haipeng Cheng; Sungho Lee; Ping Gong; Kryslaine O Lopes; Ying Chen; Nobuhisa Iwata; Ke-Jie Yin; Jin-Moo Lee; Angèle T Parent; Takaomi C Saido; Yue-Ming Li; Sangram S Sisodia; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

Review 2.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

Review 3.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

4.  Links between CD147 function, glycosylation, and caveolin-1.

Authors:  Wei Tang; Sharon B Chang; Martin E Hemler
Journal:  Mol Biol Cell       Date:  2004-06-16       Impact factor: 4.138

Review 5.  CD147 immunoglobulin superfamily receptor function and role in pathology.

Authors:  Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
Journal:  Exp Mol Pathol       Date:  2007-09-07       Impact factor: 3.362

6.  Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

Authors:  Ruth Eichner; Michael Heider; Vanesa Fernández-Sáiz; Frauke van Bebber; Anne-Kathrin Garz; Simone Lemeer; Martina Rudelius; Bianca-Sabrina Targosz; Laura Jacobs; Anna-Maria Knorn; Jolanta Slawska; Uwe Platzbecker; Ulrich Germing; Christian Langer; Stefan Knop; Herrmann Einsele; Christian Peschel; Christian Haass; Ulrich Keller; Bettina Schmid; Katharina S Götze; Bernhard Kuster; Florian Bassermann
Journal:  Nat Med       Date:  2016-06-13       Impact factor: 53.440

7.  Comparative transcriptome profiling approach to glean virulence and immunomodulation-related genes of Fasciola hepatica.

Authors:  Orçun Haçarız; Mete Akgün; Pınar Kavak; Bayram Yüksel; Mahmut Şamil Sağıroğlu
Journal:  BMC Genomics       Date:  2015-05-09       Impact factor: 3.969

Review 8.  Dealing with the family: CD147 interactions with cyclophilins.

Authors:  Vyacheslav Yurchenko; Stephanie Constant; Michael Bukrinsky
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

9.  Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells.

Authors:  Khajornsak Tragoolpua; Nutjeera Intasai; Watchara Kasinrerk; Sabine Mai; Yuan Yuan; Chatchai Tayapiwatana
Journal:  BMC Biotechnol       Date:  2008-01-29       Impact factor: 2.563

10.  CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape.

Authors:  Yatong Chen; Jing Xu; Xiaodong Wu; Hui Yao; Zhou Yan; Ting Guo; Wenjing Wang; Peixiao Wang; Yu Li; Xiangmin Yang; Hao Li; Huijie Bian; Zhi-Nan Chen
Journal:  Cell Mol Immunol       Date:  2020-11-11       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.